Will the iPad revolutionize in-clinic experience?

Will the iPad revolutionize in-clinic experience?

I wrote the above post in my pharma blog “breakthepill” way back in February 2013 (you can paste the entire phrase, with double quotation marks, in Google search bar to visit the blog. )

During those days, iPad or Tablet was a new toy on the horizon. Only the niche therapies of few pharma companies had adapted it.

Won’t it be interesting to read what was written about it almost six years back and compare it with the present realities?

Please read till the end and let me know how much of my predictions have come true and how much of my thoughts hold good even today.

Unable to think beyond the VA?

Common complaint against pharma marketers is that since decades they are not able to think beyond the Visual Aid Folder. Though laptops made few inroads here and there, but due to its prohibitive cost and low battery life coupled with long booting time, it could not replace VAs as the mainstream tool of communication.

We got an opportunity to work on iPad communication

Hence, when one of our clients told us about their decision to make a complete shift from VAs to iPads for their entire field force (It’s a super-specialty division, not a mass one), we were obviously quite excited to partner with them for the entire project.

During this process we got some powerful insights which I will share with you in due course of time.

What pharma industry has to say about the iPad?

But, this acted as a trigger for me to find out how pharma industry responds to this idea of using iPads (When I mention iPad, I am referring not just to the iPad but all other equivalent gadgets like tabs/tablet PCs etc.). I therefore spoke to many pharma marketers to find out their view on this.

As expected, marketers were not unanimous about iPads as replacement to VAs and LBLs. Some of them were totally negative, few were very positive while some were not able to decide.

Those who are against it

For those who are against it, money seems to be the major deterrent. Many of them are looking at it as an expense rather than an investment. They want to spend their money on options like CRM, etc., which they think will help them in getting better returns and are extremely uncomfortable to risk it in a new stream like iPad.

Those who are in favour of it

While those who are positive about it, have stated reasons like possibility of designing and delivering customized scientific communication, convenience, being green, reduced turnaround time in response to customer queries and enhancing field force effectiveness. When it comes to in-clinic impact, they feel that what can take many calls can be achieved by just one call with the iPad. Interestingly, the proponents of i-Pad believe that it will save recurring cost of VAs and LBLs and thus will be a cost saving proposition in the long run.

Now, as promised in the beginning let me share my first hand experience on this, along with my thoughts.

Our experience with iPad

Initially, the client believed that an iPad with science loaded in it, coupled with the ease of navigation will help in achieving a high quality customized scientific discussion inside the clinic. The outcome was not exactly as expected. The learning was that technology can’t replace skills and culture.

Our initial thought process was: “How do we adapt the brand creatives to iPad?” As long as we continued to ask this question, we continued to think with the mental model of ‘print communication’. Then we tweaked the question slightly: “If iPad is going to be the medium, how do I create powerful communication?” Suddenly the mental model changed, we found ourselves thinking about ‘videos’. The outcome changed radically. Now we were able to bring that “wow” factor. There is still a long way to go, but iPads have now opened the floodgate of exhilarating possibilities.

Though I had stated earlier that ‘iPad’ is being referred to in the generic sense and it is applicable to other tabs or tablet PCs, here I would like to go into the specifics. The technology of iPad is best-in-class and the benefits are well known. But from an e-detailing perspective, iPad has one major drawback. It does not support the flash player. You can still input your flash based communication into the iPad. But every time you want to do it, you need outside help to design a program that will enable inputting the flash based communication. This will result into a huge recurring cost.

My Thoughts

Today, for any marketer to influence the minds of his customers, he has two challenges to overcome:

  1. Creating a powerful marketing communication that can differentiate his brand from the rest
  2. Ensuring undiluted and unadulterated delivery of that communication inside the Doctor’s clinic

Now imagine a brand communication which is very creative, attention grabbing and so classy that it even matches some of the best TV commercials. (I know, the reality is completely opposite so I am asking you to just imagine). But is it of any use if its in-clinic delivery is pathetic? This is where a medium like iPad can create a much better impact. With the iPad entering the scene, marketers can no longer give low competence of field personnel as an excuse for not designing powerful communication. I believe, with iPads true brand building process will now become a reality.

Few insights

  1. Great technology alone can never get you great results. To get great results, you need great ideas. Technology is there to amplify its impact.
  2. iPad offers the ease of interactivity. This doesn’t mean that once a pharma company adapts to iPad the quality of in-clinic interaction will dramatically improve. There are couple of things that one need to understand:
  • Every organization has a deep rooted culture. For a highly interactive science driven discussion to happen, one first need to bring corrections at the cultural level, which is always a long term process.
  • There needs to be enough time allocated for representatives to develop the comfort level in handling the iPad. To hand over the iPad to the field with few hours of practice would mean a huge waste of money. Pharma companies should be willing to dedicate few days exclusively for practicing and handling the iPad
  1. Will iPad completely replace or reduce the importance of field force? No, I don’t think so. iPad will be like an addition of a powerful weapon in their armamentarium.

Future possibilities

This is just the tip of the iceberg. The future is likely to be far different compared to the past and even the present. Based on the signals that are coming from different parts of the world, I see that the future is going to present an interesting scenario:

Interaction with the end consumer. This will include both patients as well as care givers. The apps are already changing the way we live our lives. Soon, we will witness a similar trend in healthcare too.

Doctors from the western countries have already started moving or will soon be moving to iPad. Sooner or later, Indian physicians too will catch up with the trend. This opens up a flood of possibilities like increased involvement of Doctors in social media, ease of connectivity with international speakers through webinars, delivering patient education in an interactive manner, formation of hundreds of big online communities of doctors and ease of sharing the information among homogeneous groups.

Final Word

Opportunity lies in spotting the trends early. As long as you look at it as an expense, you are missing the bigger picture and therefore a better opportunity. The pharma companies who will be early adapters will have the advantage of having enough time to learn the rope and reap the maximum benefit. Those who always believe in ‘wait and watch’ should keep in mind that this will be too costly a bus to miss. If they wait too long, they won’t be around to be a part of the revolution.



Dr. Sandeep Narula

Professor and Head; Management Education professional with extensive Pharmaceuticals, Healthcare, and Hospital Industry Experience.

5 年

Very well written Mr.Miliind Harrdas?- I am also advocating the same i.e.PHYGITAL - as it is my belief that PHYGITAL is the future and the companies have to invest a lot in the DIgital and also in training the people to use tech-tools and gadgets. Doctors have already embraced the Digital and are far ahead than the Pharma companies.

Sujatha Santhanam

Communication Facilitator & Leadership Coach; Certified NLP Master Practitioner; Creative Consultant; Partner & Creative Head @InkSpeak Creative

5 年

Very well articulated. I believe every change needs acceptance to succeed. Technology took time to permeate into pharma but is here to stay. However, without good ideas even technology can't do wonders for a brand.

回复

Excellent post and fantastic insight Miliind Harrdas. Technology is just a tool. From VA to iPad definitely changes the game to give an enterprise, the competitive edge. I understand that print meduim still has its place. But a well planned tool, which is giving an output through an iPad also gathers valuable inputs through the same medium i.e iPad. Making data available to marketing, ready for analysis. And Appreciably an advantage. We have seen enterprises who have not adapted to technology changes, have lost their world no #1 ranking to Asian brand. Adapting to right technology will still be a challenge at macro level. But once done will take the enterprise a long way.

Sushil Barkur

Driving Learning Culture @ Alkem Laboratories Ltd. | Doctoral Scholar (PhD) in OB & HRM IIM-Nagpur | PGCHRM-16, ISABS-ODCP, Talent Management, Culture Change, L&D, Leadership Development, Executive Coach

6 年

Excellent observation and trend reading of digital technology effecting pharmaceutical prescription business.

Gaurav Sharma

Head of GBS Service Enablement & Hub Director

6 年

Well written article! Technology is an enabler and iPad as a device for detailing to the Doctors has certain advantages over printed VAs. But device alone cannot ensure success — one needs to have robust CLM platform to back it up, a sound Content Strategy in place so that relevant, MLR approved content can be being generated and provision to measure the impact of detailing (KPIs). Also, it is important to consider in-clinic detailing as part of over-arching campaign using an Omnichannel approach to communicate with Doctors based on their preferences and not Pharma company’s prerogative. And not to forget the training aspect of field force and marketing managers in adopting technology to their advantage while communicating with their customers.

要查看或添加评论,请登录

Miliind Harrdas的更多文章

社区洞察

其他会员也浏览了